Table 2.

Correlation of MRPS12 mRNA expression and clinical prognosis in OV with different clinicopathological factors by Kaplan–Meier plotter.

	Overall survival (n = )(time = 120months)			Progression-free survival (n = ) (time = 120months)
Clinicopathological characteristics	N	Hazard ratio	P value	N	Hazard ratio	P value
STAGE
1 + 2	179	1.52 (0.69–3.37)	.2986	163	1.86 (1.04–3.35)	.0347∗
3 + 4	1268	1.2 (1.03–1.39)	.0196∗	1081	1.13 (0.97–1.31)	.1204
GRADE
1 + 2	381	1.22 (0.89–1.68)	.2114	293	1.18 (0.87–1.61)	.2814
2 + 3	1024	1.16 (0.99–1.35)	.0602	1093	1.08 (0.93–1.26)	.3147
Histology
Serous	1232	1.19 (1.01–1.39)	.0374∗	1104	1.09 (0.94–1.26)	.2351
Endometroid	62	0.36 (0.06–2.18)	.2476	51	2.28 (0.81–6.41)	.107
TP53 mutation
Mutated	516	1.45 (1.15–1.82)	.0015∗	483	1.24 (0.98–1.55)	.0696
Wild type	106	0.63 (0.32–1.26)	.1856	84	0.7 (0.4–1.22)	.2065